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Monday, February 17, 2014 327abroadly tuned chemosensor TRPA1. In several models of chemonociception in
mice and humans, we have found that CA only produces very weak avoidance,
pain or visceral irritation responses. Furthermore, CA induces a dramatic
decrease in the velocity of conduction and the amplitude of compound action
potentials in the mouse tail. Noting the structural similarities between CA and
classical local anesthetics, we investigated whether CA inhibits voltage-gated
sodium channels (VGSC) expressed in sensory neurons. We found that CA in-
hibits TTX-sensitive voltage-dependent sodium currents in a concentration
dependent manner in mouse trigeminal neurons with an IC50 of 1.5 mM.
TTX-resistant sodium currents were inhibited with an IC50 of 0.8 mM.
TTX-sensitive VGSC recorded in the immortalized DRG neuron-derived
F11 cells were inhibited with an IC50 of 1.3 mM. CA modified the gating
of TTX-sensitive sodium channels, inducing concentration-dependent shifts
of the activation curve to depolarized voltages and shifts of the availability
curve to more hyperpolarized voltages. In the presence of CA, the correspond-
ing slope factors became significantly larger. CA-induced inhibition was
enhanced at depolarized holding potentials. Inhibition of TTX-sensitive so-
dium channels was not frequency dependent and can occur when the channels
are in resting/closed state(s). We conclude that CA inhibits VGSC in sensory
neurons at concentrations that can be pharmacologically relevant, and that the
mechanism of inhibition shares similarities with the action of local
anesthetics.
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Brugada Syndrome (BrS) is an inherited cardiac arrhythmia implicated in
SIDS and sudden death in young men. BrS is caused by loss-of-function mu-
tations in the cardiac voltage-gated sodium channel NaV1.5. The decrease in
sodium current can lead to electrical abnormalities in the ventricular action po-
tential that can degenerate into ventricular tachycardia. The ECG phenotype
and electrical abnormalities associated with BrS are not always present and
are often unmasked clinically with sodium channel blockers. Paradoxically,
BrS associated arrhythmias manifest during and after exercise as well as in
sleeping infants. We hypothesize that one trigger for arrhythmias in BrS
may be extracellular acidosis, which can occur during both exercise and sleep
apnea. We used whole-cell patch clamp to characterize 3 BrS mutants, R376H,
R1193Q, and E1784K, at pH 7.4 and pH 6.0. At pH 7.4 all mutants have
reduced current compared to WT channels and there are changes in channel
activation and fast inactivation. At pH 6.0, E1784K showed the largest
proton-dependent effect with a 20 mV depolarizing shift in the midpoint
voltage of activation compared to the 12 mV shift in WT. All 3 mutants
showed decreased function at pH 6.0 although the magnitude of the shifts
was not always different fromWT. Overall, extracellular acidosis would be ex-
pected to challenge already decreased sodium currents, particularly in the
E1784K mutant. Therefore, acidosis may be one of the triggers for arrhythmia
in BrS patients.
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BACKGROUND: enhancement of the sustained component of the sodium cur-
rent (INaL) is a major factor contributing to myocardial damage. A beneficial
effect of the INaL blocker Ranolazine (RAN) on glycemic control was recently
described in the MERLIN-TIMI 36 trial in diabetic patients. However, the
mechanism underlying this finding hasn’t been elucidated yet.
AIM: To characterize INaL in insulin-secreting cells (INS-1E) and evaluate its
role in glucose-stimulated insulin secretion (GSIS).
METHODS: INaL, identified as the steady-state current blocked by 10 mM
RAN (IRAN) or 0.5 mM TTX (ITTX), and its impact on membrane potential
(Vm) were assessed by patch clamp. Veratridine (VERA) was used as INaL
enhancer. INaL-dependent intracellular Ca2þ changes were detected by Fluo-
4AM. To simulate hyperglycemic stress (CHG), INS-1E cells were exposed
to 33 mM glucose for 24 hrs. GSIS was measured by HTRF assay.
RESULTS: Glucose- and tolbutamide-triggered action potentials were sup-
pressed by TTX, but not by RAN. VERA caused depolarization, countered
by INaL blockade. The reversal potentials of ITTX and IRAN were negative
to Naþ equilibrium potential, but they approached it when Kþ-channels
were blocked. This revealed INaL coupling to Naþ-activated Kþ current
(IKNa); expression of IKNa channels (Slo2.1/2.2) was confirmed by transcriptanalysis. INaL blockade blunted cytosolic Ca2þ response to depolarization.
CHG enhanced INaL. Whereas acute INaL enhancement (VERA) increased
GSIS, chronic one (CHG or VERA) depressed GSIS, which was partially
restored by RAN.
CONCLUSIONS: INaL is expressed in insulin-secreting cells, is coupled to
IKNa , affects Ca2þ signalling and, when enhanced acutely, increases GSIS.
However, constitutive INaL enhancement, induced by chronic hyperglycemic
stress, and leads to GSIS depression instead. Overall, chronic INaL enhance-
ment may represent a mechanism of damage progression common to myocar-
dial and insulin-secreting cells.
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Cardiac hypertrophy, arrhythmias and heart failure are serious outcomes of an
overstimulation of renin angiotensin system. Indeed, when the type 1 angio-
tensin II (ANGII) receptor (AT1R) is overexpressed in a cardiac-specific
manner in mice all of these pathologies are recapitulated. Nonetheless, the
mechanism underlying these pathologies remain incompletely understood. Pre-
viously, we have shown that chronic stimulation of AT1R caused significant
decreases in ventricular potassium and calcium currents. To further investigate
the AT1R mediated regulation of ion channels, we examined the cardiac so-
dium current (INa) in AT1R mice. To distinguish the effect of a direct AT1R
overexpression from AT1R induced hypertrophy, mice were used before (50-
day, 50d) and after (6-month, 6m) the development of cardiac hypertrophy.
Surface ECG recordings showed that QRS complex was prolonged indepen-
dently of cardiac remodelling in AT1R mice compared to controls. (50d:
CTL: 17.050.4 ms, n=11 and AT1R: 22.251.5 ms, n=7 and 6m: CTL:
17.050.6 ms, n=9 and AT1R: 21.750.6 ms, n=9). Current-clamp recordings
revealed that the maximal velocity of the action potential (AP) upstroke
(Vmax) was reduced to a similar extent in AT1R mice of both age groups
compared to controls (50d: CTL: 10754, n=20, AT1R: 7654, n=22; 6m:
CTL: 11157, n=12, AT1R: 6455, n=13). Lastly, voltage-clamp recordings
showed a 65% reduction in INa density in AT1R mice of both ages (at
45mV, 50d: CTL: 41.852.6 pA/pF, n=26, AT1R: 14.151.1 pA/pF,
n=23; 6m: CTL: 38.053.1 pA/pF, n=13 and AT1R: 13.552.1 pA/pF,
n=7). In conclusion, overstimulation of the AT1R pathways leads to INa reduc-
tion and results in severe cardiac electrical disturbances which occurred before
the development of cardiac hypertrophy suggesting they are not secondary to
hypertrophy.
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Some cardiac arrhythmias are associated with mutations in the cardiac voltage-
gated sodium channel (NaV1.5), including long QT3 syndrome (gain-of-func-
tion mutations) and Brugada syndrome (loss-of-function mutations). Two mu-
tations, E1784K and R1193Q are associated with both syndromes, whereas
R376H is a Brugada syndrome mutation. We tested the effects of temperature
on gating in wild-type (WT) NaV1.5 and these three mutations. Whole-cell
patch clamp experiments were performed on CHO cells transiently transfected
with the NaV1.5 asubunit, the b1-subunit, and eGFP. Voltage-clamp proto-
cols were performed at either 10 C, 22 C, or 34 C. Conductance in WT was
not temperature dependent compared to the mutant channels, all of which
showed a depolarizing shift in the midpoint of the conductance curve at
10C. A significant hyperpolarizing shift in steady-state fast inactivation was
seen when temperature increased to 34 C in R1193Q. In WT and R376H,
persistent current was greater at 10 oC than at 22 oC. In contrast, persistent cur-
rent both R1193Q and E1784K had U-shaped temperature dependence in which
persistent current increased when temperature was changed from 22 C to 34
C and from 22 oC to 10 oC. E1784K and R376H had greater use-dependent
inactivation with increasing temperatures (22 C to 34 C), whereas use-
dependent inactivation in R1193Q had no thermosensitivity. This is consistent
with previous results, which show that both the E1784K and R1193Q are mixed
syndrome mutations. Although elevated temperatures may trigger long QT syn-
drome, the large stabilization in fast inactivation for R1193Q and the increase
in use-dependence for E1784K suggest a mixed syndrome phenotypic expres-
sion. The loss of function in R376H, associated with Brugada-syndrome, is
328a Monday, February 17, 2014exacerbated by elevated temperature. In summary, these results suggest tem-
perature fluctuations could be a trigger for long-QT and Brugada related
arrhythmias.
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Voltage gated sodium channels are membrane proteins that play a critical role
in electrical signaling of excitable cells. Amongst this family, the isoform
Nav1.5 is responsible for the initiation and propagation of cardiac action poten-
tials. As most of membrane proteins, Nav1.5 is well known to be a glycoprotein
with ~5% of its total weight corresponding to carbohydrates. To date, it has
been shown that Nav1.5 glycosylations such as sialylations influence biophys-
ical properties of this channel protein. However, whereas N-glycosylation are
well known post-traductional modifications that modulate surface localization
of many ionic channels, little is known about these maturation impacts on
voltage gated sodium channels. Perturbation of Nav1.5 trafficking is a well
characterized phenomenon occurring in pathology such as Brugada syndrome.
Our laboratory previously revealed that trafficking defective mutants of Nav1.5
exert a dominant negative effect upon wild type protein surface localization.
The objective of this study was (i) to characterize N-glycosylations of
Nav1.5 during its membrane trafficking and (ii) to investigate these maturations
in the context of the dominant negative effect exerted by Nav1.5 trafficking
defective mutations.
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The cardiac late Naþ current (INaL) is enhanced in hypertrophy, heart failure
and ischemia. Spontaneously hypertensive rats (SHR) are characterized by
prolonged action potential duration (APD), [Naþ]i and [Ca
2þ]i overload and
triggered activity (TA). We hypothesized that INaL is enhanced in SHR and
contribute to APD prolongation and TA. INaL was increased in ventricular my-
ocytes isolated from 10- to 12-month-old SHR (0.8450.13 pA/pF, n ¼ 16)
compared to age-matched Wistar rats (WR; 0.2650.06 pA/pF, n ¼ 9; p <
0.01). INaL inhibitors ranolazine (RAN) and GS-458967 (GS967) reduced
INaL in myocytes from SHR with IC50 of 3.750.1 and 0.6550.04 mM;
respectively. APD70 and APD90 were prolonged in myocytes from SHR,
compared to WR, and were shortened by RAN (10 mM) and GS967 (1 mM)
(Table). In 8/23myocytes from SHR, spontaneous delayed afterpotentials
(DADs) and/or TA were observed. Pacing induced DADs in 8/10 and TA
in 4/10 myocytes from SHR. GS967 (1 mM) abolished both spontaneous
and pacing induced TA (4/4).Our data
show that INaL is enhanced and contributes
to APD prolongation and TA in myocytes
from SHR. Selective inhibition of INaL
could stabilize cardiac repolarization and
suppress arrhythmias in hypertension.1665-Pos Board B395
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The late Naþ current (INa,L) is known to contribute to cardiac action potential
(AP) plateau and upregulation of INaL leads to arrhythmogenic activities. We
used an innovative self-action potential (sAP)-clamp technique to directly re-
cord the dynamic INa,L during the cell’s own AP. We studied the dynamic
INaL in rabbit ventricular myocytes under physiological conditions wherein
[Naþ]i and [Ca2þ]i homeostasis were preserved. We then determined the ef-
fect of GS967, a newly developed selective and potent inhibitor of INa,L. Re-
sults: (1) During the various phases of AP waveform, the dynamic INa,L
amplitude was low at phase-1, gradually increased during phase-2 to reach
a peak, and declined at phase-3. This profile of INa,L magnitude and time
course under AP-clamp is distinctively different from the monotonically
declining INa,L current seen under rectangular pulse voltage-clamp due to
non-equilibrium gating. (2) GS967 selectively inhibits INa,L during AP in a
concentration-dependent manner with an IC50 of 57 nM. Unlike tetrodotoxin,
GS967 did not significantly inhibit the fast Naþ current. Hence, GS967 short-ened the AP duration without affecting the AP upstroke. (3) The INa,L peak
amplitude was 0.7850.07 A/F under physiological condition. Anemonia
toxin II (ATX-II) at 5 nM increased the INaL amplitude to 1.25 50.14 A/
F, and prolonged APD95 from 212.4510.5 ms (control) to 305.6519.1 ms
(ATX-II). GS967 (1uM) effectively shortened APD and suppressed afterdepo-
larizations (EADs) induced by ATX-II. Conclusion: Our sAP-clamp data
reveal a surprisingly large INa,L during AP plateau under physiological con-
dition, which explains why INa,L significantly affect cardiac AP morphology
and arrhythmogenesis. GS967 inhibits INa,L during AP plateau without
blocking the fast Naþ current at AP upstroke, and therefore provides a prom-
ising therapeutic strategy to suppress cardiac arrhythmias without slowing
conduction.
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Nociceptive sensory neurons transmit painful stimuli from the periphery to the
central nervous system. Voltage-gated sodium (NaV) channels are instrumental
for the generation of the corresponding electrical signals, but - so far - the sen-
sory neuron-specific NaV1.9 only appeared to play a minor role. Recently, we
identified a de novo heterozygous mutation in the SCN11A gene encoding for
NaV1.9 and demonstrated the implication of NaV1.9 in human pain perception
(Leipold et al., Nature Genetics, DOI 10.1038/ng.2767). Surprisingly, in
affected individuals the mutation (L811P) leads to an inability to experience
pain by conferring gain-of-function (GOF) properties to NaV1.9. Mutant chan-
nels activate at hyperpolarized voltages and display a slow-down of channel
inactivation and deactivation, thereby causing sustained depolarization of noci-
ceptor cells and alterations of action potential characteristics. This new chan-
nelopathy is different from other pain-related NaV channel disorders: a GOF
of homologous NaV1.7 channels is associated with chronic pain, and loss of
functional NaV1.7 channels causes congenital indifference to pain. To gain
further insight into the mechanisms underlying the mutation we introduced
the homologous L-to-P mutation into channel isoforms NaV1.4 (L802P),
NaV1.7 (L957P) and NaV1.8 (L890P) and compared the functional parameters
of wild-type and mutant channels by means of the whole-cell patch-clamp tech-
nique. The L-to-P mutation shifted the activation in all channel subtypes to hy-
perpolarized potentials in the order NaV1.9 > NaV1.7 > NaV1.4 > NaV1.8.
Fast channel inactivation was slowed down most prominently in NaV1.9 and
NaV1.8, followed by NaV1.7 and NaV1.4. These results show that a homolo-
gous L-to-P mutation affects channel activation and inactivation in a subtype-
specific manner.
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Human mortality associated with status epilepticus (SE) in U.S and Canada is
21%-22%. Sudden death caused by epilepsy (SUDEP) accounts for 17% of all
SE-related casualties. Clinical evidence linked SUDEP to arrhythmias such as
conduction block and prolongation of the QT interval, an index of repolariza-
tion time, on the cardiac electrocardiogram. These observations suggest that
SE altered the activity of the cardiac sodium current (INa) involved in both
cardiac conduction and repolarization of the ventricle. We tested this hypoth-
esis by characterizing INa in ventricular cardiomyocytes of epileptic rats
induced induced by kainic acid injection. Our patch clamp results show that
epilepsy increased peak INa by 1856% and its sustained (late) component
(INaL) by 53513%. Activation of INa occurred at more negative potential in
epileptic rats and recovery from activation was significantly delayed by epi-
lepsy. Because epilepsy is known to increase the expression of neuronal chan-
nels (nNaVs) in the brain we next tested if the changes in INa were associated
with increased sensitivity to tetrodotoxin (TTX), a hallmark of nNaVs. Our
results indicate that TTX at a concentrations not affecting the cardiac sodium
channel NaV1.5 (1 nM) blocked 34% and 50% of INaL in Sham and epileptic
rats respectively. Epilepsy therefore increased the contribution of neuronal so-
dium channel to INa in the cardiac ventricle. In summary, our data indicate
that epilepsy altered INa in a manner consistent with the alterations of
